How Age, Sex, and Cancer Type Affect Subsequent Cancer Risks in Survivors

A growing body of research is shedding light on the factors that influence the risk of developing a second, distinct cancer among survivors of an initial diagnosis. A new study published in PLOS Medicine on April 28, 2026, reveals that age at first diagnosis, sex, and the type of original cancer significantly shape the likelihood of subsequent primary cancers. The findings underscore the need for tailored long-term survivorship care and risk-based monitoring as the population of cancer survivors continues to expand.

Key Findings on Subsequent Cancer Risk

The study, led by researchers at Virginia Commonwealth University, analyzed retrospective data from more than 3 million cancer survivors in the United States. The team examined how demographic and clinical characteristics correlated with the development of subsequent primary cancers—new malignancies distinct from the original diagnosis. The results highlight several critical risk factors:

• Older age at the time of the initial cancer diagnosis was associated with a higher risk of developing a second cancer.
• Male survivors faced a greater likelihood of subsequent cancers compared to female survivors.
• Survivors of specific cancer types—including lung cancer, bladder cancer, and skin melanoma—were at elevated risk for new primary cancers.

The study’s first author, Hui Cheng, emphasized the broader implications of these findings. By examining nearly five decades of national data, we found population-level shifts in subsequent primary cancer risk, with several survivor groups experiencing rising risks, Cheng noted. The research suggests that as survival rates improve and the number of cancer survivors grows, targeted prevention and surveillance strategies will become increasingly important.

Why These Factors Matter

The study’s results align with earlier research indicating that cancer survivors remain at heightened risk for new malignancies due to a combination of genetic, environmental, and treatment-related factors. For example, exposure to radiation or chemotherapy during initial treatment may increase the likelihood of developing a second cancer later in life. Lifestyle factors such as smoking, obesity, and poor diet can further elevate risk.

The influence of age and sex on subsequent cancer risk is particularly noteworthy. Older survivors may face increased vulnerability due to cumulative exposure to carcinogens over time, as well as age-related declines in immune function. Meanwhile, the higher risk observed among male survivors could reflect differences in biology, lifestyle, or healthcare-seeking behaviors between men and women.

The type of initial cancer also plays a pivotal role. Survivors of lung, bladder, and skin melanoma cancers were found to be at particularly high risk for subsequent malignancies. These findings suggest that certain cancer types may share underlying risk factors or biological pathways that predispose survivors to additional cancers.

Implications for Survivorship Care

The study’s authors stress that these findings reinforce the importance of long-term survivorship care. As the number of cancer survivors in the U.S. Is projected to grow by 22% over the next decade—from 18 million in 2025 to more than 22 million by 2035—healthcare systems will need to adapt to meet the unique needs of this population. Risk-based monitoring, personalized prevention strategies, and survivorship care plans tailored to individual risk profiles could help mitigate the burden of subsequent cancers.

For survivors, these findings underscore the importance of ongoing vigilance. Regular screenings, healthy lifestyle choices, and open communication with healthcare providers can play a critical role in early detection and prevention. However, the study also highlights the need for further research to better understand the mechanisms driving subsequent cancer risk and to develop more effective interventions.

Adolescent and Young Adult Survivors Face Unique Risks

While the PLOS Medicine study focused on a broad population of cancer survivors, separate research has highlighted the unique challenges faced by adolescents and young adults (AYAs) who survive cancer. A population-based study from Alberta, Canada, published in the Canadian Medical Association Journal (CMAJ) on April 13, 2026, found that survivors of cancer diagnosed during adolescence and young adulthood face a significantly elevated risk of subsequent primary neoplasms.

The study, led by Arafat Ul Alam of the University of Calgary, analyzed data from 24,459 AYA cancer survivors. Among this group, 1,442 individuals developed subsequent primary neoplasms, with 1,129 of these cases occurring more than five years after the initial diagnosis. The findings suggest that AYA survivors may require specialized long-term follow-up care to address their heightened risk.

The standardized incidence ratio for subsequent primary neoplasms in AYA survivors was found to be twofold higher than in the general population, translating to 35.7 excess cases per 10,000 person-years. This elevated risk underscores the need for tailored surveillance and prevention strategies for this vulnerable group.

What Remains Uncertain

While the new research provides valuable insights into the risk factors for subsequent cancers, several questions remain unanswered. For instance, the specific biological mechanisms linking certain cancer types to higher risks of subsequent malignancies are not yet fully understood. The role of genetic predisposition, environmental exposures, and treatment-related factors in shaping these risks requires further investigation.

the study’s reliance on retrospective data means that some variables—such as lifestyle factors or socioeconomic status—could not be fully accounted for. Future research incorporating prospective data and more detailed patient histories may help refine risk assessments and inform more precise prevention strategies.

For now, the findings serve as a critical reminder of the long-term challenges faced by cancer survivors. As the survivor population grows, so too does the need for comprehensive, personalized care that addresses not only the immediate aftermath of cancer but also the ongoing risks that survivors may face decades after their initial diagnosis.

A Call for Action

The rising tide of cancer survivors presents both an opportunity and a challenge for healthcare systems worldwide. By identifying the groups at highest risk for subsequent cancers, studies like these can help guide the development of targeted interventions, improved surveillance guidelines, and more effective survivorship care plans. For survivors, the message is clear: while the journey does not end with the initial diagnosis, proactive measures can help mitigate the risks and improve long-term outcomes.

As Hui Cheng and her colleagues note, the shifting landscape of cancer survivorship demands a proactive and adaptive approach. By identifying survivor groups at heightened risk, studies like this can help to inform tailored prevention strategies, surveillance guidelines, and survivorship care planning as the cancer survivor population continues to grow, the researchers concluded.